20-Hydroxyeicosatetraenoic acid (20-HETE) stimulates migration of vascular smooth muscle cells

Cellular Physiology and Biochemistry

Volumn 19, Issue 1-4, 2007, Pages 121-128

  Stec, David E ^a,b   Gannon, Kimberly P ^a   Beaird, Janis S ^a   Drummond, Heather A ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^b Center for Excellence in Cardiovascular Renal Research   (United States)

Author keywords

20 Hydroxyeicosatetraenoic Acid; Cyp4A; Migration; PDGF BB; Second messengers; Vascular smooth muscle

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 20 HYDROXYICOSATETRAENOIC ACID; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PLATELET DERIVED GROWTH FACTOR BB; TYRPHOSTIN; WORTMANNIN;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL MIGRATION; CONTROLLED STUDY; EMBRYO; ENZYME INHIBITION; NONHUMAN; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

RATTUS;

EID: 33847019630     PISSN: 10158987     EISSN: None     Source Type: Journal    
DOI: 10.1159/000099200     Document Type: Article

References (26)

1. Imig JD, Zou AP, Stec DE, Harder DR, Falck JR, Roman RJ: Formation and actions of 20-hydroxyeicosatetraenoic acid in rat renal arterioles. American Journal of Physiology-Regulatory Integrative and Comparative Physiology 1996;39(1):R217-R227.
2. Zou AP, Fleming JT, Falck JR, Jacobs ER, Gebremedhin D, Harder DR et al: 20-HETE is an endogenous inhibitor of the large-conductance Ca2+-activated K+ channel in renal arterioles. American Journal of Physiology-Regulatory Integrative and Comparative Physiology 1996;39(1):R228-R237.
3. Sun CW, Alonso-Galicia M, Taheri MR, Falck JR, Harder DR, Roman RJ: Nitric oxide-20-hydroxyeicosatetraenoic acid interaction in the regulation of K+ channel activity and vascular tone in renal arterioles Circ Res 1998;83(11):1069-1079.
4. Uddin MR, Muthalif MM, Karzoun NA, Benter IF, Malik KU: Cytochrome P-450 metabolites mediate norepinephrine-induced mitogenic signaling Hypertension 1998;31(1 Pt 2):242-247.
5. Muthalif MM, Benter IF, Karzoun N, Fatima S, Harper J, Uddin MR et al: 20-Hydroxyeicosatetraenoic acid mediates calcium/calmodulin-dependent protein kinase II-induced mitogen-activated protein kinase activation in vascular smooth muscle cells Proc Natl Acad Sci U S A 1998;95(21):12701-12706.
6. Lin F, Rios A, Falck JR, Belosludtsev Y, Schwartzman ML: 20-Hydroxyeicosatetraenoic acid is formed in response to EGF and is a mitogen in rat proximal tubule Am J Physiol 1995;269(6 Pt 2):F806-F816.
7. Muthalif MM, Uddin MR, Fatima S, Parmentier JH, Khandekar Z, Malik KU: Small GTP binding protein Ras contributes to norepinephrine-induced mitogenesis of vascular smooth muscle cells. Prostaglandins Other Lipid Mediat 2001;65(1):33-43.
8. Yaghini FA, Zhang C, Parmentier JH, Estes AM, Jafari N, Schaefer SA et al: Contribution of arachidonic acid metabolites derived via cytochrome P4504A to angiotensin II-induced neointimal growth Hypertension 2005;45(6):1182-1187.
9. Amaral SL, Maier KG, Schippers DN, Roman RJ, Greene: AS CYP4A metabolites of arachidonic acid and VEGF are mediators of skeletal muscle angiogenesis Am J Physiol Heart Circ Physiol 2003;284(5):H1528-H1535.
10. Jiang M, Mezentsev A, Kemp R, Byun K, Falck JR, Miano JM et al: Smooth muscle-specific expression of CYP4A1 induces endothelial sprouting in renal arterial microvessels Circ Res 2004;94(2):167-174.
11. Marji JS, Wang MH, Laniado-Schwartzman M: Cytochrome P-450 4A isoform expression and 20-HETE synthesis in renal preglomerular arteries Am J Physiol Renal Physiol 2002;283(1):F60-F67.
12. Grifoni SD, Gannon KA, Stec DE, Drummond HA. ENaC proteins contribute to VSMC migration. Am J Physiol Heart Circ Physiol 2006, in press.
13. Zou AP, Ma YH, Sui ZH, Ortiz de Montellano PR, Clark JE, Masters BS et al: Effects of 17-octadecynoic acid, a suicide-substrate inhibitor of cytochrome P450 fatty acid omega-hydroxylase, on renal function in rats J Pharmacol Exp Ther 1994;268(1):474-481.
14. Miyata N, Taniguchi K, Seki T, Ishimoto T, Sato-Watanabe M, Yasuda Y et al: HET0016, a potent and selective inhibitor of 20-HETE synthesizing enzyme Br J Pharmacol 2001;133(3):325-329.
15. Alonso-Galicia M, Falck JR, Reddy KM, Roman RJ: 20-HETE agonists and antagonists in the renal circulation. Am J Physiol 1999;277(5 Pt 2):F790-F796.
16. Willis AI, Pierre-Paul D, Sumpio BE, Gahtan V: Vascular smooth muscle cell migration: current research and clinical implications. Vasc Endovascular Surg 2004;38(1):11-23.
17. Nakao J, Ooyama T, Ito H, Chang WC, Murota S: Comparative effect of lipoxygenase products of arachidonic acid on rat aortic smooth muscle cell migration Atherosclerosis 1982;44(3):339-342.
18. Snyder GD, Krishna UM, Falck JR, Spector AA: Evidence for a membrane site of action for 14,15-EET on expression of aromatase in vascular smooth muscle. Am J Physiol Heart Circ Physiol 2002;283(5):H1936-H1942.
19. Wong PY, Lin KT, Yan YT, Ahern D, Iles J, Shen SY et al: 14(R),15(S)-epoxyeicosatrienoic acid (14(R),15(S)-EET) receptor in guinea pig mononuclear cell membranes J Lipid Mediat 1993;6(1-3):199-208.
20. Wong PY, Lai PS, Falck JR: Mechanism and signal transduction of 14 (R), 15 (S)-epoxyeicosatrienoic acid (14,15-EET) binding in guinea pig monocytes. Prostaglandins Other Lipid Mediat 2000;62(4):321-333.
21. Alonso-Galicia M, Sun CW, Falck JR, Harder DR, Roman RJ: Contribution of 20-HETE to the vasodilator actions of nitric oxide in renal arteries. Am J Physiol 1998;275(3 Pt 2):F370-F378.
22. Pukac L, Huangpu J, Karnovsky MJ: Platelet-derived growth factor-BB, insulin-like growth factor-I, and phorbol ester activate different signaling pathways for stimulation of vascular smooth muscle cell migration Exp Cell Res 1998;242(2):548-560.
23. Chen Y, Medhora M, Falck JR, Pritchard KA, Jr., Jacobs ER: Mechanisms of activation of eNOS by 20-HETE and VEGF in bovine pulmonary artery endothelial cells. Am J Physiol Lung Cell Mol Physiol 2006;291(3):L378-L385.
24. Chen JK, Falck JR, Reddy KM, Capdevila J, Harris RC: Epoxyeicosatrienoic acids and their sulfonimide derivatives stimulate tyrosine phosphorylation and induce mitogenesis in renal epithelial cells. J Biol Chem 1998;273(44):29254- 29261.
25. Chen P, Guo M, Wygle D, Edwards PA, Falck JR, Roman RJ et al: Inhibitors of cytochrome P450 4A suppress angiogenic responses. Am J Pathol 2005;166(2):615-624.
26. Guo M, Roman RJ, Fenstermacher JD, Brown SL, Falck JR, Arbab AS et al: 9L gliosarcoma cell proliferation and tumor growth in rats are suppressed by N-hydroxy-N′-(4-butyl-2-methylphenol) formamidine (HET0016), a selective inhibitor of CYP4A. J Pharmacol Exp Ther 2006;317(1):97-108.